Healthcare -
Biotechnology - NASDAQ - US
$ 11.87
-0.785 %
$ 172 M
Market Cap
0.1
P/E
INBX - CASH FROM OPERATIONS
Cash from Operations INBX - Inhibrx Biosciences, Inc.
-194 M
LAST VALUE
-29.85%
2 YEAR CAGR
-43.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR